APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Anti-Infectives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Anti-Infectives Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchVeterinary Anti-Infectives Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Anti-Infectives Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Veterinary Anti-Infectives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Anti-Infectives Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Anti-Infectives Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Anti-Infectives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Anti-Infectives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Anti-Infectives market include Zoetis Animal Healthcare, Merck, Bayer Healthcare, Virbac, Merial (Sanofi), Elanco, Ceva Animal Health and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Anti-Infectives market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Anti-Infectives and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Anti-Infectives revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Anti-Infectives market.

Veterinary Anti-Infectives Segment by Company

Zoetis Animal Healthcare

Merck

Bayer Healthcare

Virbac

Merial (Sanofi)

Elanco

Ceva Animal Health

Boehringer Ingelheim

Veterinary Anti-Infectives Segment by Type

Oxytetracycline

Freeze-dried Ceftiofur

Marbofloxacin

Florfenicol

Aminosidine

Beta-lactams

Veterinary Anti-Infectives Segment by Application

Companion Animals

Farm Animals

Others

Veterinary Anti-Infectives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Anti-Infectives status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Anti-Infectives key companies, revenue, market share, and recent developments.

3. To split the Veterinary Anti-Infectives breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Anti-Infectives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Anti-Infectives significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Anti-Infectives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Anti-Infectives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Anti-Infectives industry.

Chapter 3: Detailed analysis of Veterinary Anti-Infectives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Anti-Infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Anti-Infectives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Anti-Infectives Industry Trends Table 2. Veterinary Anti-Infectives Industry Drivers Table 3. Veterinary Anti-Infectives Industry Opportunities and Challenges Table 4. Veterinary Anti-Infectives Industry Restraints Table 5. Global Veterinary Anti-Infectives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Anti-Infectives Revenue Share by Company (2021-2026) Table 7. Global Veterinary Anti-Infectives Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Anti-Infectives Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Anti-Infectives Company, Product Type & Application Table 10. Global Veterinary Anti-Infectives Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Anti-Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oxytetracycline Table 15. Significant Companies of Freeze-dried Ceftiofur Table 16. Significant Companies of Marbofloxacin Table 17. Significant Companies of Florfenicol Table 18. Significant Companies of Aminosidine Table 19. Significant Companies of Beta-lactams Table 20. Global Veterinary Anti-Infectives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Veterinary Anti-Infectives Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Veterinary Anti-Infectives Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Veterinary Anti-Infectives Sales Value Share by Type (2021-2026) Table 24. Global Veterinary Anti-Infectives Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Companion Animals Table 26. Significant Companies of Farm Animals Table 27. Significant Companies of Others Table 28. Global Veterinary Anti-Infectives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Veterinary Anti-Infectives Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Veterinary Anti-Infectives Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Veterinary Anti-Infectives Sales Value Share by Application (2021-2026) Table 32. Global Veterinary Anti-Infectives Sales Value Share by Application (2027-2032) Table 33. Global Veterinary Anti-Infectives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary Anti-Infectives Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Veterinary Anti-Infectives Sales Value Share by Region (2021-2026) Table 36. Global Veterinary Anti-Infectives Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Veterinary Anti-Infectives Sales Value Share by Region (2027-2032) Table 38. Global Veterinary Anti-Infectives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Veterinary Anti-Infectives Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Veterinary Anti-Infectives Sales Value Market Share by Country (2021-2026) Table 41. Global Veterinary Anti-Infectives Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Veterinary Anti-Infectives Sales Value Market Share by Country (2027-2032) Table 43. Zoetis Animal Healthcare Company Information Table 44. Zoetis Animal Healthcare Business Overview Table 45. Zoetis Animal Healthcare Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Zoetis Animal Healthcare Veterinary Anti-Infectives Product Portfolio Table 47. Zoetis Animal Healthcare Recent Development Table 48. Merck Company Information Table 49. Merck Business Overview Table 50. Merck Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Merck Veterinary Anti-Infectives Product Portfolio Table 52. Merck Recent Development Table 53. Bayer Healthcare Company Information Table 54. Bayer Healthcare Business Overview Table 55. Bayer Healthcare Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Bayer Healthcare Veterinary Anti-Infectives Product Portfolio Table 57. Bayer Healthcare Recent Development Table 58. Virbac Company Information Table 59. Virbac Business Overview Table 60. Virbac Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Virbac Veterinary Anti-Infectives Product Portfolio Table 62. Virbac Recent Development Table 63. Merial (Sanofi) Company Information Table 64. Merial (Sanofi) Business Overview Table 65. Merial (Sanofi) Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merial (Sanofi) Veterinary Anti-Infectives Product Portfolio Table 67. Merial (Sanofi) Recent Development Table 68. Elanco Company Information Table 69. Elanco Business Overview Table 70. Elanco Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Elanco Veterinary Anti-Infectives Product Portfolio Table 72. Elanco Recent Development Table 73. Ceva Animal Health Company Information Table 74. Ceva Animal Health Business Overview Table 75. Ceva Animal Health Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ceva Animal Health Veterinary Anti-Infectives Product Portfolio Table 77. Ceva Animal Health Recent Development Table 78. Boehringer Ingelheim Company Information Table 79. Boehringer Ingelheim Business Overview Table 80. Boehringer Ingelheim Veterinary Anti-Infectives Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim Veterinary Anti-Infectives Product Portfolio Table 82. Boehringer Ingelheim Recent Development Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Veterinary Anti-Infectives Product Image Figure 2. Global Veterinary Anti-Infectives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Anti-Infectives Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Anti-Infectives Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oxytetracycline Image Figure 8. Freeze-dried Ceftiofur Image Figure 9. Marbofloxacin Image Figure 10. Florfenicol Image Figure 11. Aminosidine Image Figure 12. Beta-lactams Image Figure 13. Global Veterinary Anti-Infectives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Veterinary Anti-Infectives Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Anti-Infectives Sales Value Share by Type (2021-2032) Figure 16. Companion Animals Image Figure 17. Farm Animals Image Figure 18. Others Image Figure 19. Global Veterinary Anti-Infectives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Veterinary Anti-Infectives Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Anti-Infectives Sales Value Share by Application (2021-2032) Figure 22. Global Veterinary Anti-Infectives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Veterinary Anti-Infectives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Veterinary Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 25. North America Veterinary Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Veterinary Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Veterinary Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Veterinary Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Veterinary Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Veterinary Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 31. South America Veterinary Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Veterinary Anti-Infectives Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Veterinary Anti-Infectives Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Oxytetracycline
  • Freeze-dried Ceftiofur
  • Marbofloxacin
  • Florfenicol
  • Aminosidine
  • Beta-lactams
Applications
  • Companion Animals
  • Farm Animals
  • Others
Companies covered
  • Zoetis Animal Healthcare
  • Merck
  • Bayer Healthcare
  • Virbac
  • Merial (Sanofi)
  • Elanco
  • Ceva Animal Health
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Anti-Infectives Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Anti-Infectives Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Anti-Infectives Market Dynamics
  1. 2.1 Veterinary Anti-Infectives Industry Trends
  2. 2.2 Veterinary Anti-Infectives Industry Drivers
  3. 2.3 Veterinary Anti-Infectives Industry Opportunities and Challenges
  4. 2.4 Veterinary Anti-Infectives Industry Restraints
3 Veterinary Anti-Infectives Market by Company
  1. 3.1 Global Veterinary Anti-Infectives Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Anti-Infectives Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Anti-Infectives Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Anti-Infectives Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Anti-Infectives Company Product Type and Application
  6. 3.6 Global Veterinary Anti-Infectives Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Anti-Infectives Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Anti-Infectives Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Anti-Infectives Market by Type
  1. 4.1 Veterinary Anti-Infectives Type Introduction
  2. 4.1.1 Oxytetracycline
  3. 4.1.2 Freeze-dried Ceftiofur
  4. 4.1.3 Marbofloxacin
  5. 4.1.4 Florfenicol
  6. 4.1.5 Aminosidine
  7. 4.1.6 Beta-lactams
  8. 4.2 Global Veterinary Anti-Infectives Sales Value by Type
  9. 4.2.1 Global Veterinary Anti-Infectives Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Veterinary Anti-Infectives Sales Value by Type (2021-2032)
  11. 4.2.3 Global Veterinary Anti-Infectives Sales Value Share by Type (2021-2032)
5 Veterinary Anti-Infectives Market by Application
  1. 5.1 Veterinary Anti-Infectives Application Introduction
  2. 5.1.1 Companion Animals
  3. 5.1.2 Farm Animals
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Anti-Infectives Sales Value by Application
  6. 5.2.1 Global Veterinary Anti-Infectives Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Anti-Infectives Sales Value by Application (2021-2032)
  8. 5.2.3 Global Veterinary Anti-Infectives Sales Value Share by Application (2021-2032)
6 Veterinary Anti-Infectives Regional Value Analysis
  1. 6.1 Global Veterinary Anti-Infectives Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Anti-Infectives Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Anti-Infectives Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Anti-Infectives Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Anti-Infectives Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Anti-Infectives Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Anti-Infectives Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Anti-Infectives Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Anti-Infectives Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Anti-Infectives Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Anti-Infectives Sales Value Share by Country, 2025 VS 2032
7 Veterinary Anti-Infectives Country-level Value Analysis
  1. 7.1 Global Veterinary Anti-Infectives Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Anti-Infectives Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Anti-Infectives Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Anti-Infectives Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Anti-Infectives Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Anti-Infectives Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Anti-Infectives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis Animal Healthcare
  2. 8.1.1 Zoetis Animal Healthcare Company Information
  3. 8.1.2 Zoetis Animal Healthcare Business Overview
  4. 8.1.3 Zoetis Animal Healthcare Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Animal Healthcare Veterinary Anti-Infectives Product Portfolio
  6. 8.1.5 Zoetis Animal Healthcare Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Veterinary Anti-Infectives Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Bayer Healthcare
  14. 8.3.1 Bayer Healthcare Company Information
  15. 8.3.2 Bayer Healthcare Business Overview
  16. 8.3.3 Bayer Healthcare Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Healthcare Veterinary Anti-Infectives Product Portfolio
  18. 8.3.5 Bayer Healthcare Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Veterinary Anti-Infectives Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Merial (Sanofi)
  26. 8.5.1 Merial (Sanofi) Company Information
  27. 8.5.2 Merial (Sanofi) Business Overview
  28. 8.5.3 Merial (Sanofi) Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merial (Sanofi) Veterinary Anti-Infectives Product Portfolio
  30. 8.5.5 Merial (Sanofi) Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Veterinary Anti-Infectives Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 Ceva Animal Health
  38. 8.7.1 Ceva Animal Health Company Information
  39. 8.7.2 Ceva Animal Health Business Overview
  40. 8.7.3 Ceva Animal Health Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Animal Health Veterinary Anti-Infectives Product Portfolio
  42. 8.7.5 Ceva Animal Health Recent Developments
  43. 8.8 Boehringer Ingelheim
  44. 8.8.1 Boehringer Ingelheim Company Information
  45. 8.8.2 Boehringer Ingelheim Business Overview
  46. 8.8.3 Boehringer Ingelheim Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim Veterinary Anti-Infectives Product Portfolio
  48. 8.8.5 Boehringer Ingelheim Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst